Quince Therapeutics Stock (NASDAQ: QNCX) stock price, news, charts, stock research, profile.
Open | $0.75 |
Close | $0.79 |
Volume / Avg. | 38.52K / 97.95K |
Day Range | 0.75 - 0.82 |
52 Wk Range | 0.63 - 1.43 |
Market Cap | $32.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 5.2% |
Days to Cover | 29.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quince Therapeutics (NASDAQ:QNCX) through any online brokerage.
Other companies in Quince Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Immuneering (NASDAQ:IMRX) and Palatin Techs (AMEX:PTN).
There is no analysis for Quince Therapeutics.
There is no analysis for Quince Therapeutics to provide a consensus price target.
The stock price for Quince Therapeutics (NASDAQ: QNCX) is $0.7857 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Quince Therapeutics.
Quince Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Quince Therapeutics.
Quince Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.